In contrast, another retrospective study (n = 136) reported that positive CD73 expression was strongly correlated with longer disease-free survival (P = 0.0044) and overall survival (P = 0.027) of breast cancer patients [25], which suggested that elevated CD73 expression could predict a good prognosis in stages I–III breast cancer patients. Here, NT5E is linked to breast cancer.